SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Ron M who wrote (28064)2/14/1999 10:11:00 AM
From: WR  Respond to of 31646
 
Good Morning Ron, That is good news, the best of all this is that now we can see that the fix is in the works! I got some sleep last night so I have nothing new to add. WR



To: Ron M who wrote (28064)2/14/1999 10:23:00 AM
From: WR  Read Replies (1) | Respond to of 31646
 
Ron The article was Great! WR

jsonline.com



To: Ron M who wrote (28064)2/14/1999 10:23:00 PM
From: Karl Drobnic  Respond to of 31646
 
Milwaukee article: It cites a pharmaceutical with 125 factories. Wasn't that the number of factories covered by the Bristol Myers contract. Inventory cost: $11.5 million - sounds like TAVA got that money. Remediation cost: $54.8 million. If TAVA got some of that, that's a nice piece of backlog.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News